Albert Saiz

33.7k total citations · 3 hit papers
249 papers, 14.2k citations indexed

About

Albert Saiz is a scholar working on Neurology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Albert Saiz has authored 249 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Neurology, 124 papers in Pathology and Forensic Medicine and 57 papers in Molecular Biology. Recurrent topics in Albert Saiz's work include Multiple Sclerosis Research Studies (119 papers), Autoimmune Neurological Disorders and Treatments (82 papers) and Peripheral Neuropathies and Disorders (76 papers). Albert Saiz is often cited by papers focused on Multiple Sclerosis Research Studies (119 papers), Autoimmune Neurological Disorders and Treatments (82 papers) and Peripheral Neuropathies and Disorders (76 papers). Albert Saiz collaborates with scholars based in Spain, United States and United Kingdom. Albert Saiz's co-authors include Francesc Graus, Josep Dalmau, Lídia Sabater, Yolanda Blanco, Eugenia Martínez‐Hernández, Thaís Armangué, Maarten J. Titulaer, Iñigo Gabilondo, María Sepúlveda and Núria Gresa‐Arribas and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Albert Saiz

240 papers receiving 13.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

2013 2.0k citations Thaís Armangué, Takahiro Iizuka et al. profile →
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

2018 502 citations Orhan Aktaş, J. de Sèze et al. profile →
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder

2019 415 citations Takashi Yamamura, Ingo Kleiter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert Saiz Spain	63	10.4k	3.9k	2.5k	2.3k	2.1k	249	14.2k
Andrew McKeon United States	66	10.8k 1.0×	4.0k 1.0×	2.1k 0.8×	1.9k 0.8×	1.2k 0.6×	260	13.2k
Joseph E. Parisi United States	62	6.6k 0.6×	6.4k 1.6×	2.5k 1.0×	2.1k 0.9×	491 0.2×	180	16.0k
Jérôme Honnorat France	70	9.7k 0.9×	884 0.2×	3.3k 1.3×	4.3k 1.8×	1.8k 0.8×	449	16.7k
Francesc Graus Spain	99	28.3k 2.7×	4.0k 1.0×	5.7k 2.3×	6.6k 2.8×	5.5k 2.6×	437	35.2k
D. A. S. Compston United Kingdom	63	4.3k 0.4×	7.7k 1.9×	2.3k 0.9×	851 0.4×	565 0.3×	180	13.5k
Sven Jarius Germany	54	8.7k 0.8×	9.5k 2.4×	1.9k 0.8×	1.0k 0.4×	341 0.2×	205	13.3k
Gianluigi Mancardi Italy	60	3.2k 0.3×	5.2k 1.3×	2.6k 1.0×	1.8k 0.8×	349 0.2×	320	14.3k
Jan J.G.M. Verschuuren Netherlands	65	9.1k 0.9×	622 0.2×	4.7k 1.9×	1.9k 0.8×	924 0.4×	283	15.4k
Elisabeth Tournier‐Lasserve France	67	10.2k 1.0×	856 0.2×	4.2k 1.7×	1.3k 0.6×	924 0.4×	230	16.6k
Bethan Lang United Kingdom	54	9.7k 0.9×	535 0.1×	2.7k 1.1×	2.1k 0.9×	1.7k 0.8×	167	11.7k

Countries citing papers authored by Albert Saiz

Since Specialization

Citations

This map shows the geographic impact of Albert Saiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Saiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Saiz more than expected).

Fields of papers citing papers by Albert Saiz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Saiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Saiz. The network helps show where Albert Saiz may publish in the future.

Co-authorship network of co-authors of Albert Saiz

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Saiz. A scholar is included among the top collaborators of Albert Saiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Saiz. Albert Saiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calvi, Alberto, Elisabeth Solana, Baris Kanber, et al.. (2025). Diffusivity anisotropy signature of the slowly expanding lesions predicts progression independent of relapse activity in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. jnnp–2025.

Businaro, Pietro, Laura Naranjo, Jesús Planagumà, et al.. (2025). Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II). Neurology Neuroimmunology & Neuroinflammation. 12(4). e200406–e200406. 2 indexed citations

Olivé-Cirera, Gemma, Li‐Wen Chen, Fernando Paredes-Carmona, et al.. (2025). Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders. Neurology Neuroimmunology & Neuroinflammation. 12(4). e200400–e200400. 1 indexed citations

Bennett, Jeffrey L., Kazuo Fujihara, Albert Saiz, et al.. (2025). Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study. Neurology Neuroimmunology & Neuroinflammation. 12(5). e200450–e200450. 1 indexed citations

Solana, Elisabeth, Alberto Calvi, Lee B. Reid, et al.. (2024). Microscopic fractional anisotropy outperforms multiple sclerosis lesion assessment and clinical outcome associations over standard fractional anisotropy tensor. Human Brain Mapping. 45(8). e26706–e26706. 2 indexed citations

Sepúlveda, María, Raquel Ruiz‐García, Núria Martínez‐Cibrián, et al.. (2024). CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD. Neurology Neuroimmunology & Neuroinflammation. 11(5). e200292–e200292. 16 indexed citations

Olivé-Cirera, Gemma, Arlette L. Bruijstens, Li‐Wen Chen, et al.. (2024). MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders. Neurology. 102(7). e209199–e209199. 6 indexed citations

Casas-Roma, Jordi, Eloy Martínez‐Heras, Albert Solé‐Ribalta, et al.. (2022). Applying multilayer analysis to morphological, structural, and functional brain networks to identify relevant dysfunction patterns. Network Neuroscience. 6(3). 916–933. 17 indexed citations

Sepúlveda, María, Sara Llufriú, Eugenia Martínez‐Hernández, et al.. (2021). Incidence and Impact of COVID-19 in MS. Neurology Neuroimmunology & Neuroinflammation. 8(2). 28 indexed citations

10.

Martínez‐Hernández, Eugenia, Mar Guasp, Anna García‐Serra, et al.. (2020). Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies. Neurology. 94(22). e2302–e2310. 83 indexed citations

11.

Petit‐Pedrol, Mar, Mar Guasp, Thaís Armangué, et al.. (2020). Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus Syndrome. Neurology. 96(7). e1082–e1087. 7 indexed citations

12.

Papp, Viktoria, Melinda Magyari, Orhan Aktaş, et al.. (2020). Worldwide Incidence and Prevalence of Neuromyelitis Optica. Neurology. 96(2). 59–77. 165 indexed citations

13.

Sepúlveda, María, Thaís Armangué, Lídia Sabater, et al.. (2019). Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease. Multiple Sclerosis and Related Disorders. 28. 230–234. 18 indexed citations

14.

Sepúlveda, María, Carmen Montejo, Sara Llufriú, et al.. (2019). Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors. Multiple Sclerosis and Related Disorders. 38. 101483–101483. 21 indexed citations

15.

Solà‐Valls, Núria, Yolanda Blanco, Elisabeth Solana, et al.. (2018). Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 27. 333–339. 18 indexed citations

16.

Llufriú, Sara, Eloy Martínez‐Heras, Elisabeth Solana, et al.. (2016). Structural networks involved in attention and executive functions in multiple sclerosis. NeuroImage Clinical. 13. 288–296. 83 indexed citations

17.

Ramo‐Tello, Cristina, Laia Grau‐López, Mar Tintoré, et al.. (2013). A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS. Multiple Sclerosis Journal. 20(6). 717–725. 48 indexed citations

18.

Boronat, Anna, Lídia Sabater, Albert Saiz, Josep Dalmau, & Francesc Graus. (2011). GABA _B receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders. Neurology. 76(9). 795–800. 203 indexed citations

19.

Saiz, Albert, Yolanda Blanco, Lídia Sabater, et al.. (2008). Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 131(10). 2553–2563. 432 indexed citations

20.

Graus, Francesc & Albert Saiz. (2005). [Limbic encephalitis: a probably under-recognized syndrome].. PubMed. 20(1). 24–30. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact